Ademi LLP is investigating Ra Medical (NYSE American: RMED) for possible breaches of fiduciary duty and other violations of law in its transaction with Catheter Precision.
Ademi LLP alleges Ra Medical transaction with Catheter Precision may not be fair to Ra Medical’s shareholders.
We are investigating the conduct of Ra Medical’s board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.